You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

60 Items

Use of 5-HT3 Receptor Antagonists in Patients Receiving Moderately or Highly Emetogenic Chemotherapy

Document Status: Archived
ID: 12-3

Jan 2003

Use of Adjuvant Chemotherapy Following Cystectomy in Patients with Deep Muscle-Invasive Transitional Cell Carcinoma of the Bladder

Document Status: Archived
ID: 3-2-1

Oct 2012

Use of Chemotherapy in Advanced Unresectable or Metastatic Transitional Cell Carcinoma of the Bladder or Urothelium

Document Status: Archived
ID: 3-12

Nov 2011

Use of Gemcitabine in the Treatment of Advanced Pancreatic Adenocarcinoma

Document Status: Archived
ID: 2-10

Sep 2011

Use of Irinotecan (Camptosar®, CPT-11) Combined with 5-Fluorouracil and Leucovorin (5FU/LV) as First-Line Therapy for Metastatic Colorectal Cancer

Document Status: Archived
ID: 2-16b
Version: 2

Sep 2011

Use of Irinotecan in the Second-Line Treatment of Metastatic Colorectal Cancer

Document Status: Archived
ID: 2-16

Sep 2011

Use of Neoadjuvant Chemotherapy in Transitional Cell Carcinoma of the Bladder

Document Status: Archived
ID: 3-2-2 Version 2
Version: 2

Nov 2012

Use of Preoperative Chemotherapy With or Without Postoperative Radiotherapy in Technically Resectable Stage IIIA Non-Small Cell Lung Cancer

Document Status: Archived
ID: 7-4
Version: 2

Dec 2017

Use of Raltitrexed (Tomudex) in the Management of Metastatic Colorectal Cancer

Document Status: Archived
ID: 2-17

Sep 2011

Vinorelbine in Stage IV Breast Cancer

Document Status: Archived
ID: 1-4

Sep 2012

Zoledronic Acid as Adjuvant Therapy in Combination with Adjuvant Endocrine Therapy for Premenopausal Women with Early-Stage Hormone Receptor Positive Breast Cancer

Document Status: Archived
ID: CED 16

Jan 2010

Zoledronic Acid for Metastatic Renal Cell Carcinoma (MRCC)

Document Status: Archived
ID: CED 18

Jun 2010